IL6 and cancer: To expand upon the concept of using RPPA as a sensitive biomarker discovery platform for low-abundance antigens or proteins expressed by low-frequency cancer sub-clones [37], we studied the expression of two markers, IL-6 and TGF-β, reportedly shuttled in EVs and over-expressed in advanced cancers [6, 24].